Increased expression of BNIP3 was correlated with increased drug sensitivity of cancer cells to Cisplatin, Carboplatin and Gemcitabine (Figures 11D–F), whereas it was negatively correlated with drug sensitivity of cancer cells to Sunitinib, Palbociclib, and Trametinib (Figures 11G–I). This evidence concerns the gene BNIP3 and cancer.